
Willie J. Daniel Jr.
Examiner (ID: 12204, Phone: (571)272-7907 , Office: P/2462 )
| Most Active Art Unit | 2462 |
| Art Unit(s) | 2462, 2465, 2641, 2617, 2686 |
| Total Applications | 889 |
| Issued Applications | 433 |
| Pending Applications | 99 |
| Abandoned Applications | 374 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18954083
[patent_doc_number] => 20240042410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => PROCESS FOR PREPARING MICROCAPSULES
[patent_app_type] => utility
[patent_app_number] => 18/462228
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18462228
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/462228 | PROCESS FOR PREPARING MICROCAPSULES | Sep 5, 2023 | Pending |
Array
(
[id] => 19164804
[patent_doc_number] => 11980686
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-05-14
[patent_title] => Agomelatine oral transmucosal film
[patent_app_type] => utility
[patent_app_number] => 18/462245
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6115
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18462245
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/462245 | Agomelatine oral transmucosal film | Sep 5, 2023 | Issued |
Array
(
[id] => 19096236
[patent_doc_number] => 20240115463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => SUSTAINED RELEASE DRUG DELIVERY SYSTEMS WITH REDUCED IMPURITIES AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/235256
[patent_app_country] => US
[patent_app_date] => 2023-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18235256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/235256 | SUSTAINED RELEASE DRUG DELIVERY SYSTEMS WITH REDUCED IMPURITIES AND RELATED METHODS | Aug 16, 2023 | Abandoned |
Array
(
[id] => 19279878
[patent_doc_number] => 20240216350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE
[patent_app_type] => utility
[patent_app_number] => 18/449747
[patent_app_country] => US
[patent_app_date] => 2023-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18449747
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/449747 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | Aug 14, 2023 | Pending |
Array
(
[id] => 18893653
[patent_doc_number] => 20240009138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => EDIBLE GRAPHIC DRUG DELIVERY SYSTEM AND METHOD OF MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 18/355325
[patent_app_country] => US
[patent_app_date] => 2023-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18355325
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/355325 | EDIBLE GRAPHIC DRUG DELIVERY SYSTEM AND METHOD OF MANUFACTURE | Jul 18, 2023 | Pending |
Array
(
[id] => 19629532
[patent_doc_number] => 20240407981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => Crushable Capsule Beads Containing Cuticle Moisturizing Oils
[patent_app_type] => utility
[patent_app_number] => 18/208279
[patent_app_country] => US
[patent_app_date] => 2023-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18208279
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/208279 | Crushable Capsule Beads Containing Cuticle Moisturizing Oils | Jun 10, 2023 | Abandoned |
Array
(
[id] => 19599534
[patent_doc_number] => 20240390414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => USE OF SODIUM THIOSULFATE (STS) WITH AND WITHOUT COFACTORS FOR THE TREATMENT OF INFLAMMATORY, NEURODEGENERATIVE AND NEUROPSYCHIATRIC CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/208186
[patent_app_country] => US
[patent_app_date] => 2023-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18208186
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/208186 | USE OF SODIUM THIOSULFATE (STS) WITH AND WITHOUT COFACTORS FOR THE TREATMENT OF INFLAMMATORY, NEURODEGENERATIVE AND NEUROPSYCHIATRIC CONDITIONS | Jun 8, 2023 | Abandoned |
Array
(
[id] => 18986298
[patent_doc_number] => 20240058267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => SLURRY AND SOLUTION COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/140124
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18140124
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/140124 | SLURRY AND SOLUTION COMPOSITIONS | Apr 26, 2023 | Abandoned |
Array
(
[id] => 18565813
[patent_doc_number] => 20230256140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/308409
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18308409
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/308409 | ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES | Apr 26, 2023 | Abandoned |
Array
(
[id] => 18565812
[patent_doc_number] => 20230256139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => IMPLANT SURFACES FOR PAIN CONTROL
[patent_app_type] => utility
[patent_app_number] => 18/138588
[patent_app_country] => US
[patent_app_date] => 2023-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18138588
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/138588 | IMPLANT SURFACES FOR PAIN CONTROL | Apr 23, 2023 | Pending |
Array
(
[id] => 18595893
[patent_doc_number] => 20230270683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/134687
[patent_app_country] => US
[patent_app_date] => 2023-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18134687
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/134687 | TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS | Apr 13, 2023 | Abandoned |
Array
(
[id] => 18708029
[patent_doc_number] => 20230330614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => PYRACLOSTROBIN MICROCAPSULE BASED ON SODIUM ALGINATE AND PREPARATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/131871
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131871
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/131871 | Pyraclostrobin microcapsule based on sodium alginate and preparation method | Apr 6, 2023 | Issued |
Array
(
[id] => 18483455
[patent_doc_number] => 20230210750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Organic Compounds
[patent_app_type] => utility
[patent_app_number] => 18/174233
[patent_app_country] => US
[patent_app_date] => 2023-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18174233
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/174233 | Organic Compounds | Feb 23, 2023 | Abandoned |
Array
(
[id] => 18389730
[patent_doc_number] => 20230157948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID DISPERSION OF NILOTINIB
[patent_app_type] => utility
[patent_app_number] => 18/100104
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100104
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100104 | ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID DISPERSION OF NILOTINIB | Jan 22, 2023 | Abandoned |
Array
(
[id] => 18389790
[patent_doc_number] => 20230158008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 18/080379
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080379
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/080379 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS | Dec 12, 2022 | Pending |
Array
(
[id] => 18404453
[patent_doc_number] => 20230165803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/993555
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17993555
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/993555 | BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS | Nov 22, 2022 | Pending |
Array
(
[id] => 18230058
[patent_doc_number] => 20230069052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METALLIC BANDAGE
[patent_app_type] => utility
[patent_app_number] => 17/984701
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/984701 | METALLIC BANDAGE | Nov 9, 2022 | Pending |
Array
(
[id] => 18626606
[patent_doc_number] => 20230285400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/982024
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982024
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982024 | Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the same | Nov 6, 2022 | Issued |
Array
(
[id] => 19049545
[patent_doc_number] => 20240091514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => Transdermal Double-layer Microneedle Based on Hydrogen Producing Probiotics and Its Preparation Method and Application
[patent_app_type] => utility
[patent_app_number] => 17/967943
[patent_app_country] => US
[patent_app_date] => 2022-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17967943
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/967943 | Transdermal Double-layer Microneedle Based on Hydrogen Producing Probiotics and Its Preparation Method and Application | Oct 17, 2022 | Pending |
Array
(
[id] => 18296201
[patent_doc_number] => 20230105887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => NOVEL PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/047180
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047180
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047180 | NOVEL PHARMACEUTICAL COMPOSITION | Oct 16, 2022 | Abandoned |